Latest news

Aortyx, a biomedical company that develops a minimally invasive solution for aortic dissection, has closed a funding round for EUR 13.8M

Suma Capital, through SC Net Zero Ventures, an investment fund specialising in sustainability scale-ups, has joined two other international leaders, ABB and VERBUND X Ventures, in the EUR 12M funding round closed by Hybrid Energy Store Solutions (HESSTEC)

RCD has advised the biopharmaceutical company, aptaTargets, on an agreement with the German multinational pharmaceutical company Merck KGaA for the clinical development and commercialisation of ApTOLL, a Toll-like receptor 4 (TLR4) antagonist being developed for acute ischaemic stroke

We advised Fundeen, a participatory financing platform that specialises in renewable energy, on the investment of the IB Deuda España impact fund, managed by Impact Bridge, for up to EUR 11 M, including EUR 1 M for strengthening the development of its project portfolio and an additional EUR 10 M in co-financed projects in 2025

RCD advised Pet Snack, a company that specialises in manufacturing pet food under the leading brand, Mediterranean Natural, on the acquisition of a majority stake in its share capital by Alinatur, a company operating in the same sector